AAAAAA
Results:
1-12
|
Results: 12
Authors:
Beckendorf, V
Pommier, P
Carrie, C
Bey, P
Cowen, D
Gonzague-Casabianca, L
Maingon, P
Horiot, JC
Lagrange, JL
Madelis, G
Luporsi, E
Citation: V. Beckendorf et al., Multicentre conformal radiotherapy dose escalation study for the treatmentof localized prostate cancer. Preliminary evaluation of safety and qualityof life., PROG UROL, 11(2), 2001, pp. 264-276
Authors:
Namer, M
Soler-Michel, P
Turpin, F
Chinet-Charrot, P
de Gislain, C
Pouillart, P
Delozier, T
Luporsi, E
Etienne, PL
Schraub, S
Eymard, JC
Serin, D
Ganem, G
Calais, G
Maillart, P
Colin, P
Trillet-Lenoir, V
Prevost, G
Tigaud, D
Clavere, P
Marti, P
Romieu, C
Wendling, JL
Citation: M. Namer et al., Results of a phase III prospective, randomised trial, comparing mitoxantrone and vinorelbine (MV) in combination with standard FAC/FEC in front-line therapy of metastatic breast cancer, EUR J CANC, 37(9), 2001, pp. 1132-1140
Authors:
Peiffert, D
Giovannini, M
Ducreux, M
Michel, P
Francois, E
Lemanski, C
Mirabel, X
Cvitkovic, F
Luporsi, E
Conroy, T
Gerard, JP
Citation: D. Peiffert et al., High-dose radiation therapy and neoadjuvant plus concomitant chemotherapy with 5-fluorouracil and cisplatin in patients with locally advanced squamous-cell anal canal cancer: Final results of a phase II study, ANN ONCOL, 12(3), 2001, pp. 397-404
Authors:
Bollet, MAA
Lapeyre, M
Marchal, C
Hoffstetter, S
Peiffert, D
Cornes, PGS
Luporsi, E
Bey, P
Citation: Maa. Bollet et al., Cervical lymph node relapses of head-and-neck squamous cell carcinoma: Is brachytherapy a therapeutic option?, INT J RAD O, 51(5), 2001, pp. 1305-1312
Authors:
Pourel, N
Auque, J
Bracard, S
Hoffstetter, S
Luporsi, E
Vignaud, JM
Bey, P
Citation: N. Pourel et al., Efficacy of external fractionated radiation therapy in the treatment of meningiomas: a 20-year experience, RADIOTH ONC, 61(1), 2001, pp. 65-70
Authors:
Bastit, P
Chevallier, B
Chevreau, C
Mihura, J
Roche, H
Namer, M
Gedouin, D
Kerbrat, P
Lesimple, T
Coudert, B
Fargeot, P
de Gislain, C
Mayer, F
Luporsi, E
Rios, M
Weber, B
Bremond, A
Devaux, Y
Monteuquet, P
Schraub, S
Hayat, M
Zambon, E
Grandgirard, A
Monnier, A
Sun, X
Clavere, P
Ollivier, JP
Rhein, B
Roullet, B
Chollet, P
Van Praagh, I
Cattan, A
Eymard, JC
Pourny, C
Facchini, T
Walter, S
Dides, S
Ramos, R
Guiochet, N
Seffert, P
Perpoint, X
Sztermer, JF
Cretin, J
Goudier, MJ
Morice, F
Delecroix, V
Fumoleau, P
Citation: P. Bastit et al., Epirubicin-based chemotherapy in metastatic breast cancer patients: Role of dose-intensity and duration of treatment, J CL ONCOL, 18(17), 2000, pp. 3115-3124
Authors:
Bey, P
Carrie, C
Beckendorf, V
Ginestet, C
Aletti, P
Madelis, G
Luporsi, E
Pommier, P
Cowen, D
Gonzague-Casabianca, L
Simonian-Sauve, M
Maingon, P
Naudy, S
Lagrange, JL
Marcie, S
Citation: P. Bey et al., Dose escalation with 3D-CRT in prostate cancer: French study of dose escalation with conformal 3D radiotherapy in prostate cancer - Preliminary results, INT J RAD O, 48(2), 2000, pp. 513-517
Authors:
Andrieu, N
Prevost, T
Rohan, TE
Luporsi, E
Le, MG
Gerber, M
Zaridze, DG
Lifanova, Y
Renaud, R
Lee, HP
Duffy, SW
Citation: N. Andrieu et al., Variation in the interaction between familial and reproductive factors on the risk of breast cancer according to age, menopausal status, and degree of familiality, INT J EPID, 29(2), 2000, pp. 214-223
Authors:
Mauriac, L
Blanc-Vincent, MP
Luporsi, E
Cutuli, B
Fourquet, A
Garbay, JR
Giard, S
Spyratos, F
Zafrani, B
Dilhuydy, JM
Citation: L. Mauriac et al., Standards, Options and Recommendations (SOR) for endocrine therapy in patients with non metastatic breast cancer, B CANCER, 87(6), 2000, pp. 469-490
Authors:
Beckendorf, V
Maalouf, T
George, JL
Bey, P
Leclere, J
Luporsi, E
Citation: V. Beckendorf et al., Place of radiotherapy in the treatment of Graves' orbitopathy, INT J RAD O, 43(4), 1999, pp. 805-815
Authors:
Lhomme, C
Vennin, P
Callet, N
Lesimple, T
Achard, JL
Chauvergne, J
Luporsi, E
Chinet-Charrot, P
Coudert, B
Couette, JE
Guastalla, JP
Lebrun, D
Ispas, S
Blumberg, J
Citation: C. Lhomme et al., A multicenter phase II study with triptorelin (sustained-release LHRH agonist) in advanced or recurrent endometrial carcinoma: A French Anticancer Federation study, GYNECOL ONC, 75(2), 1999, pp. 187-193
Authors:
Kaminsky-Forrett, MC
Conroy, T
Luporsi, E
Peiffert, D
Lapeyre, M
Boissel, P
Guillemin, F
Bey, P
Citation: Mc. Kaminsky-forrett et al., Prognostic implications of downstaging following preoperative radiation therapy for operable T3-T4 rectal cancer, INT J RAD O, 42(5), 1998, pp. 935-941
Risultati:
1-12
|